News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
714,639 Results
Type
Article (41851)
Company Profile (262)
Press Release (672526)
Multimedia
Podcasts (52)
Webinars (12)
Section
Business (208061)
Career Advice (2039)
Deals (35890)
Drug Delivery (98)
Drug Development (82581)
Employer Resources (173)
FDA (16389)
Job Trends (15102)
News (351565)
Policy (33140)
Tag
Academia (2658)
Accelerated approval (5)
Adcomms (21)
Allergies (88)
Alliances (50545)
ALS (92)
Alzheimer's disease (1409)
Antibody-drug conjugate (ADC) (127)
Approvals (16394)
Artificial intelligence (277)
Autoimmune disease (22)
Automation (16)
Bankruptcy (365)
Best Places to Work (11811)
BIOSECURE Act (19)
Biosimilars (108)
Biotechnology (185)
Bladder cancer (79)
Brain cancer (27)
Breast cancer (283)
Cancer (2294)
Cardiovascular disease (178)
Career advice (1707)
Career pathing (30)
CAR-T (153)
Cell therapy (432)
Cervical cancer (19)
Clinical research (66983)
Collaboration (861)
Company closure (1)
Compensation (549)
Complete response letters (19)
COVID-19 (2639)
CRISPR (42)
C-suite (249)
Cystic fibrosis (104)
Data (2234)
Decentralized trials (2)
Denatured (20)
Depression (44)
Diabetes (271)
Diagnostics (6465)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (127)
Drug pricing (102)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (88080)
Editorial (38)
Employer branding (21)
Employer resources (147)
Events (115347)
Executive appointments (755)
FDA (17673)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (773)
Gene editing (108)
Generative AI (24)
Gene therapy (314)
GLP-1 (718)
Government (4501)
Grass and pollen (5)
Guidances (67)
Healthcare (19271)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (118)
Indications (29)
Infectious disease (2784)
Inflammatory bowel disease (140)
Inflation Reduction Act (8)
Influenza (53)
Intellectual property (99)
Interviews (316)
IPO (16655)
IRA (41)
Job creations (3707)
Job search strategy (1451)
Kidney cancer (10)
Labor market (38)
Layoffs (476)
Leadership (17)
Legal (8056)
Liver cancer (76)
Lung cancer (323)
Lymphoma (155)
Machine learning (7)
Management (58)
Manufacturing (311)
MASH (68)
Medical device (13509)
Medtech (13514)
Mergers & acquisitions (19783)
Metabolic disorders (692)
Multiple sclerosis (82)
NASH (16)
Neurodegenerative disease (92)
Neuropsychiatric disorders (27)
Neuroscience (1958)
NextGen: Class of 2025 (6661)
Non-profit (4600)
Now hiring (39)
Obesity (365)
Opinion (207)
Ovarian cancer (75)
Pain (87)
Pancreatic cancer (83)
Parkinson's disease (151)
Partnered (21)
Patents (236)
Patient recruitment (113)
Peanut (48)
People (58391)
Pharmaceutical (64)
Pharmacy benefit managers (18)
Phase I (20907)
Phase II (29436)
Phase III (21944)
Pipeline (1212)
Policy (140)
Postmarket research (2650)
Preclinical (9161)
Press Release (68)
Prostate cancer (107)
Psychedelics (30)
Radiopharmaceuticals (252)
Rare diseases (391)
Real estate (6052)
Recruiting (65)
Regulatory (22673)
Reports (46)
Research institute (2437)
Resumes & cover letters (354)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (71)
Series A (135)
Series B (86)
Service/supplier (14)
Sickle cell disease (56)
Special edition (14)
Spinal muscular atrophy (154)
Sponsored (32)
Startups (3654)
State (2)
Stomach cancer (13)
Supply chain (69)
Tariffs (40)
The Weekly (30)
Vaccines (698)
Venture capitalists (41)
Weight loss (236)
Women's health (36)
Worklife (16)
Date
Today (51)
Last 7 days (919)
Last 30 days (2655)
Last 365 days (33361)
2025 (11043)
2024 (35789)
2023 (40532)
2022 (51742)
2021 (56314)
2020 (54805)
2019 (47489)
2018 (35754)
2017 (32676)
2016 (32260)
2015 (38357)
2014 (32048)
2013 (27138)
2012 (29438)
2011 (30048)
2010 (28279)
Location
Africa (747)
Alabama (53)
Alaska (7)
Arizona (238)
Arkansas (13)
Asia (38674)
Australia (6317)
California (6212)
Canada (2026)
China (532)
Colorado (272)
Connecticut (286)
Delaware (149)
Europe (84431)
Florida (930)
Georgia (207)
Idaho (57)
Illinois (551)
India (26)
Indiana (314)
Iowa (11)
Japan (164)
Kansas (104)
Kentucky (24)
Louisiana (10)
Maine (62)
Maryland (905)
Massachusetts (4675)
Michigan (220)
Minnesota (396)
Mississippi (2)
Missouri (83)
Montana (29)
Nebraska (25)
Nevada (63)
New Hampshire (69)
New Jersey (1793)
New Mexico (29)
New York (1782)
North Carolina (1081)
North Dakota (9)
Northern California (2708)
Ohio (206)
Oklahoma (14)
Oregon (35)
Pennsylvania (1395)
Puerto Rico (12)
Rhode Island (33)
South America (1126)
South Carolina (23)
South Dakota (1)
Southern California (2333)
Tennessee (103)
Texas (918)
United States (23672)
Utah (182)
Virginia (150)
Washington D.C. (64)
Washington State (561)
West Virginia (3)
Wisconsin (64)
714,639 Results for "model n inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
QPS Expands Offerings With Robust Pharmacology Disease Models, Including MASH, Ulcerative Colitis, Wound Healing, and Psoriasis
April 23, 2025
·
4 min read
Press Releases
Rosalind Franklin University Incubator Company Announces Positive Anti-Fibrotic Effects in Lung Disease Model
May 1, 2025
·
1 min read
Press Releases
Fangzhou Inc. integrates DeepSeek open-source AI Model to enhance Internet healthcare
February 18, 2025
·
3 min read
Deals
Model N to be Acquired by Vista Equity Partners For $1.25 Billion
Model N announced that it has entered into a definitive agreement to be acquired by Vista Equity Partners, a leading global investment firm focused exclusively on enterprise software, data, and technology-enabled businesses.
April 8, 2024
·
10 min read
Press Releases
NMD Pharma presents preclinical data highlighting increased innervation of skeletal muscle with ClC-1 ion channel inhibition treatment in neuromuscular disease model
March 25, 2025
·
5 min read
Press Releases
Tempus Signs Expanded Strategic Agreements with AstraZeneca and Pathos to Develop the Largest Multimodal Foundation Model in Oncology
April 23, 2025
·
5 min read
Press Releases
Skye Bioscience Demonstrates Over 30% Weight Loss with Nimacimab and Tirzepatide Combination in Preclinical Model
April 16, 2025
·
7 min read
Press Releases
Biostate AI and Weill Cornell Medicine Collaborate to Develop AI Models for Personalized Leukemia Care
April 22, 2025
·
3 min read
Press Releases
Edgewood Oncology Announces New Efficacy Data From Investigator-Sponsored Study of BTX-A51 in Preclinical Models of Liposarcoma
April 28, 2025
·
4 min read
Business
Model N Announces Date of Fourth Quarter and Fiscal Year 2023 Financial Results
Model N, Inc., the leader in revenue optimization and compliance, plans to announce financial results for the fourth quarter and fiscal year 2023 after market close on Thursday, November 9, 2023.
October 19, 2023
·
1 min read
1 of 71,464
Next
